Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

about

"Indeterminate lupus anticoagulant" as the third category.

P2860

Q42198939-9A998E38-B230-45D6-B834-84FC4873775E

P2860

Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

Item

http://www.wikidata.org/entity/Q35676030

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

@ast

Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

@en

type

Item

label

Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

@ast

Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

@en

prefLabel

Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

@ast

Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

@en

P1476

Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

@en

P2093

Khaldoun Alkayed

http://www.w3.org/2001/XMLSchema#string

P2860

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Thrombosis in patients with the lupus anticoagulant.

Epidemiology of the antiphospholipid antibody syndrome.

Antiphospholipid antibodies, malignancies and paraproteinemias.

Acquired inhibitors of blood coagulation.

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.

Prevalence of the antiphospholipid syndrome in primary systemic vasculitis

Clinical significance of superficial vein thrombosis.

Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time.

Activated protein C resistance, thrombophilia, and inflammatory bowel disease.

P304

239-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5045/KJH.2011.46.4.239

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kandice Kottke-Marchant

P577

2011-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221761303

http://www.w3.org/2001/XMLSchema#string

P698

22259629

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

3259515

http://www.w3.org/2001/XMLSchema#string

Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

about

P2860

P2860

Indeterminate lupus anticoagulant results: Prevalence and clinical significance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932